09 Jan 2020 SELLAS Commences Pivotal Phase 3 REGAL Study of Galinpepimut-S (GPS) in Patients with Acute Myeloid Leukemia (AML)
09 Jan 2020 Phase I clinical trial results published for Invectys DNA Vaccine for Cancer using PharmaJet Needle-free injector
07 Jan 2020 Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers
30 Dec 2019 HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-201 for the Treatment of Human Papillomavirus 16-Positive Cancers
27 Dec 2019 Sinovac Announces Approval of Varicella Vaccine for Prevention of Varicella-Zoster Virus (Chickenpox) in Children
20 Dec 2019 Vaccitech Oncology Limited Enters Collaboration with Cancer Research UK to Fund a Phase I/IIa Clinical Trial as First-Line NSCLC Therapy
20 Dec 2019 First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response
16 Dec 2019 Heat Biologics Announces First Patient Dosed in the First Phase 1 Trial of HS-130
15 Dec 2019 Gritstone Oncology Reports Promising Early Immunogenicity Activity and Safety Data from its Phase 1 Studies Evaluating its Neoantigen-based Immunotherapies, GRANITE and SLATE
13 Dec 2019 Soligenix Initiates Clinical Trial of its Heat Stable Ricin Toxin Vaccine
13 Dec 2019 Transgene Reports on the Combination Trial of TG4010, Chemotherapy and Nivolumab in Non-Small Cell Lung Cancer
11 Dec 2019 GemVax announced phase II results of GV1001 for Alzheimer's disease treatment at CTAD 2019
10 Dec 2019 Emergex Successfully Completes Preclinical Testing of its Lead ‘Set-Point’ Vaccine Candidate for Dengue Fever and Other Flaviviruses
09 Dec 2019 Nouscom - First Patient Dosed in a Phase 1 Trial With NOUS-209, an 'off-the-shelf' Neoantigen Cancer Vaccine, in MSI-High Solid Tumors
06 Dec 2019 Meissa Vaccines Receives FDA Clearance of IND Application for a Phase 1 Clinical Trial of MV-012-968 for Respiratory Syncytial Virus
05 Dec 2019 Osivax Enters Agreement with U.S. National Institutes of Health to Test Universal Flu Vaccine Candidate
04 Dec 2019 Advaxis Announces Submission of IND Application for ADXS-HOT Drug Candidate for Prostate Cancer
26 Nov 2019 Prokarium announces MHRA acceptance to run Phase I trial of lead vaccine against enteric fever
26 Nov 2019 Vaccitech Provides Update on Clinical Progress for its Two Phase 2 Universal Influenza Studies
24 Nov 2019 Takeda Presents 18-Month Data from Pivotal Phase 3 Trial of Dengue Vaccine Candidate at the American Society of Tropical Medicine and Hygiene (ASTMH) 68th Annual Meeting
23 Nov 2019 Emergent BioSolutions Presents Positive Immunogenicity Results From Phase 2 Study of Its Investigational Chikungunya VLP Vaccine Candidate
22 Nov 2019 Elios Therapeutics Presents Primary Analysis of Phase IIb Study Showing Personalized Cancer Vaccine Significantly Reduces Risk of Melanoma Recurrence in High-Risk Patients
22 Nov 2019 VBI Vaccines Presents Early GBM Tumor Response and Immunologic Data from Part B of Ongoing Phase 1/2a Study of VBI-1901 at the 2019 SNO Annual Meeting
19 Nov 2019 Enrollment and Randomization of 12,463 Participants Complete in BiondVax's Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine trial
18 Nov 2019 Valneva Reports Excellent Final Phase 1 Results for its Chikungunya Vaccine Candidate, Confirms Plans

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up